Clinical Trials Browser

Phase 2 × pasireotide × 90 days × Clear all

NCT06295952 2026-03-04

A Study of Pasireotide in People With Prolactinoma

Phase 2 Recruiting

Prolactin-Producing Pituitary Tumor